Long-term therapeutic efficacy of interferon for patients with chronic hepatitis C
β Scribed by Takeda, Tadashi ;Kuroki, Tetsuo ;Fukuda, Katsuhiko ;Yabusako, Tsuneo ;Nishiguchi, Shuhei ;Nakajima, Shinya ;Shiomi, Susumu ;Seki, Shuichi ;Monna, Takeyuki ;Sakurai, Masami ;Kobayashi, Kenzo
- Publisher
- Springer-Verlag
- Year
- 1993
- Tongue
- English
- Weight
- 334 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Hepatocellular carcinoma (HCC) occurs in patients with hepatitis Yasuji Arase, M
We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986
## Abstract Studies were undertaken to investigate whether interferon therapy could induce hepatitis C virus (HCV) carriage with normal serum alanine aminotransferase (ALT) values using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 53 patients
We studied the long-term outcomes of 43 patients with chronic hepatitis C treated with one or two interferon cycles, in relation to hepatitis C virus RNA in serum and peripheral-blood mononuclear cells. After the first interferon cycle, 15 (35%) patients had normal transaminase levels, although only